Skip to main content
. 2021 Oct 8;12:718917. doi: 10.3389/fendo.2021.718917

Table 3.

Characteristics of the patients according to clinical observed response group.

Clinical Observed Response
Null/Nearly-zero 1(n=8) Decreased 2(n=11) Normal 3(n=47) Increased 4(n=13) p value
Characteristics [median
(5ème-95ème percentiles)]
Age (years) 27.5
[21-32]
28
[22-34]
28
[20.4-36]
29
[23-35.6]
0.900
BMI (kg/m2) 27,8
[18.4-35.7]
27
[19-33.4]
25,2
[19-35.85]
24
[18.5-32.1]
0.715
AMH
(pmol/L)
130.15
[63-115.2]
84.8
[35-111.8]
72.15
[22.4-185]
51,25
[35.8-118.5]
0.020
AFC 81.5
[33-115.2]
75
[29-114.1]
54
[17.8-93]
47
[30-136.2]
0.051

1: no response at 150 mg; 2: 1 or 2 follicles at 150 mg; 3: 1 or 2 follicles at 50 or 100 mg; 4: > 2 follicles at 50 mg.

Data in bold are p-values and are non-significant (NS) if greater than or equal to 0.05.